martindale.com
Legal Library
|
Summary of FDA Advertising and Promotion Enforcement Activities by Scott Cunningham
Covington & Burling LLP - Washington Office
Scott D. Danzis
Covington & Burling LLP - Washington Office
Michael S. Labson
Covington & Burling LLP - Washington Office
Erika Lietzan
Covington & Burling LLP - Washington Office
Julia Post
Covington & Burling LLP - Washington Office
|
|
August 2, 2012
Previously published on July 26, 2012
This e-alert is part of a series of monthly e-alerts summarizing publicly-available FDA enforcement letters (i.e., warning letters and untitled letters) relating to the advertising and promotion of drugs, biologics, and medical devices. In June 2012, FDA’s Office of Prescription Drug Promotion (OPDP) posted the following enforcement letters on its website:
|
The views expressed in this document are solely the views of the author and not Martindale-Hubbell. This document is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance. |
| | View More Library Documents By... | | | |
| | | | Covington & Burling LLP Overview |
Practice Area Resource Centers
|
|